US 8586536
Neprilysin inhibitors
granted A61KA61K31/42A61K31/422
Quick answer
US patent 8586536 (Neprilysin inhibitors) held by Theravance, Inc. expires Mon Nov 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Nov 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K31/42, A61K31/422, A61K31/5377, A61K45/06